BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 21836075)

  • 21. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
    Milman G; Schwope DM; Gorelick DA; Huestis MA
    Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance.
    Karschner EL; Swortwood MJ; Hirvonen J; Goodwin RS; Bosker WM; Ramaekers JG; Huestis MA
    Drug Test Anal; 2016 Jul; 8(7):682-9. PubMed ID: 26097154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration.
    Milman G; Barnes AJ; Schwope DM; Schwilke EW; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Anal Bioanal Chem; 2011 Aug; 401(2):599-607. PubMed ID: 21637933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of antioxidants on the long-term stability of THC and related cannabinoids in sampled whole blood.
    Sørensen LK; Hasselstrøm JB
    Drug Test Anal; 2018 Feb; 10(2):301-309. PubMed ID: 28570781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
    Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
    J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of cannabinoid concentrations in oral fluid and whole blood between occasional and regular cannabis smokers prior to and after smoking a cannabis joint.
    Fabritius M; Chtioui H; Battistella G; Annoni JM; Dao K; Favrat B; Fornari E; Lauer E; Maeder P; Giroud C
    Anal Bioanal Chem; 2013 Dec; 405(30):9791-803. PubMed ID: 24202191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing cannabis consumption frequency: Is the combined use of free and glucuronidated THCCOOH blood levels of diagnostic utility?
    Hädener M; Martin Fabritius M; König S; Giroud C; Weinmann W
    Drug Test Anal; 2017 Jul; 9(7):1043-1051. PubMed ID: 27732768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis.
    Schwope DM; Bosker WM; Ramaekers JG; Gorelick DA; Huestis MA
    J Anal Toxicol; 2012 Jul; 36(6):405-12. PubMed ID: 22589524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.
    Bergamaschi MM; Karschner EL; Goodwin RS; Scheidweiler KB; Hirvonen J; Queiroz RH; Huestis MA
    Clin Chem; 2013 Mar; 59(3):519-26. PubMed ID: 23449702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and quantification of cannabinoids in postmortem fluids and tissues by liquid chromatography-tandem mass spectrometry.
    Cliburn KD; Huestis MA; Wagner JR; Kemp PM
    J Chromatogr A; 2021 Aug; 1652():462345. PubMed ID: 34198104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry.
    Scheidweiler KB; Desrosiers NA; Huestis MA
    Clin Chim Acta; 2012 Nov; 413(23-24):1839-47. PubMed ID: 22771478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.
    Andersson M; Scheidweiler KB; Sempio C; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2016 Sep; 408(23):6461-71. PubMed ID: 27422645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration.
    Lee D; Vandrey R; Milman G; Bergamaschi M; Mendu DR; Murray JA; Barnes AJ; Huestis MA
    Anal Bioanal Chem; 2013 Sep; 405(23):7269-79. PubMed ID: 23831756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration.
    Milman G; Barnes AJ; Schwope DM; Schwilke EW; Darwin WD; Goodwin RS; Kelly DL; Gorelick DA; Huestis MA
    Clin Chem; 2010 Aug; 56(8):1261-9. PubMed ID: 20530732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH).
    Holland MG; Schwope DM; Stoppacher R; Gillen SB; Huestis MA
    Forensic Sci Int; 2011 Oct; 212(1-3):247-51. PubMed ID: 21764230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoids in exhaled breath following controlled administration of smoked cannabis.
    Himes SK; Scheidweiler KB; Beck O; Gorelick DA; Desrosiers NA; Huestis MA
    Clin Chem; 2013 Dec; 59(12):1780-9. PubMed ID: 24046200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.
    Schwilke EW; Schwope DM; Karschner EL; Lowe RH; Darwin WD; Kelly DL; Goodwin RS; Gorelick DA; Huestis MA
    Clin Chem; 2009 Dec; 55(12):2180-9. PubMed ID: 19833841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.
    Milman G; Barnes AJ; Lowe RH; Huestis MA
    J Chromatogr A; 2010 Feb; 1217(9):1513-21. PubMed ID: 20083251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.